2022
DOI: 10.1016/j.bioorg.2022.105824
|View full text |Cite
|
Sign up to set email alerts
|

Targeted modifications of neomycin and paromomycin: Towards resistance-free antibiotics?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 116 publications
0
10
0
Order By: Relevance
“…1 H NMR (300 MHz, CDCl 3 ) δ 7.27 (s, 10H), 6.17 (s, 1H), 5.55 (s, 1H), 4.64−4.60 (m, 6H), 4.49 (s, 1H), 4.40 (t, J = 3.7 Hz, 2H), 2.60 (s, 3H); 13 C{ 1 H} NMR (75 MHz, CDCl 3 ) δ 215. 5, 137.3, 128.4, 127.9, 103.2, 73.9, 72.3, 71.7, 69.9, 68.4 6,8-Bis(benzyloxy)-2,4,10-trioxaadamantane (6). Hypophosphorous acid (50 wt % in H 2 O, 322.4 mg, 4.89 mmol) was added to a solution of 5 (450.0 mg, 0.98 mmol), triethylamine (1.09 g, 1.5 mL, 10.8 mmol), and 1,4-dioxane (3.3 mL).…”
Section: ■ Results and Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…1 H NMR (300 MHz, CDCl 3 ) δ 7.27 (s, 10H), 6.17 (s, 1H), 5.55 (s, 1H), 4.64−4.60 (m, 6H), 4.49 (s, 1H), 4.40 (t, J = 3.7 Hz, 2H), 2.60 (s, 3H); 13 C{ 1 H} NMR (75 MHz, CDCl 3 ) δ 215. 5, 137.3, 128.4, 127.9, 103.2, 73.9, 72.3, 71.7, 69.9, 68.4 6,8-Bis(benzyloxy)-2,4,10-trioxaadamantane (6). Hypophosphorous acid (50 wt % in H 2 O, 322.4 mg, 4.89 mmol) was added to a solution of 5 (450.0 mg, 0.98 mmol), triethylamine (1.09 g, 1.5 mL, 10.8 mmol), and 1,4-dioxane (3.3 mL).…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…DOIA is also present in a group of aminoglycoside antibiotics, inosamycins, and is the biosynthetic precursor of 2-deoxystreptamine (DOS), the aglycone of several clinically important antibiotics, such as gentamicin, kanamycin, and neomycin . Recently, these aminoglycosides have been found to be effective inhibitors of heptosyltransferase I, critical to the biosynthesis of lipopolysaccharides present on bacterial cell surfaces, and modifications on the aminoglycosides have been disclosed as a promising way to yield new antibiotics . Preliminary study on nabscessins A and B also showed that they possess moderate antimicrobial activity against Cryptococcus neoformans .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Paromomycin is a water‐soluble broad‐spectrum aminoglycoside antibiotic derived from S. rimosus var . paromomycinus , which is structurally related to neomycin (neomycin has a 6′‐amino group, paromomycin has a 6′‐hydroxyl; Obszynski et al., 2022). The antibacterial properties of paromomycin are also similar to neomycin.…”
Section: Short Examples Of Riboswitch Biosensingmentioning
confidence: 99%
“…After enzymic modification, the resulting products decrease or lose their affinity to the drug target and then decrease or lose their antibacterial activity. To tackle this problem, proactive structural modification on these drugs have been extensively investigated [ 4 , 5 , 6 , 7 ]. Through chemical modification, some sensitive groups on the drug molecules are eliminated or masked.…”
Section: Introductionmentioning
confidence: 99%